HEADER HYDROLASE 15-OCT-10 3P94 TITLE CRYSTAL STRUCTURE OF A GDSL-LIKE LIPASE (BDI_0976) FROM TITLE 2 PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.93 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: GDSL-LIKE LIPASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: SEQUENCE DATABASE RESIDUES 25-227; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PARABACTEROIDES DISTASONIS; SOURCE 3 ORGANISM_TAXID: 435591; SOURCE 4 STRAIN: ATCC 8503 / DSM 20701 / NCTC 11152; SOURCE 5 GENE: BDI_0976; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS SERINE HYDROLASE, CATALYTIC TRIAD, GDSL-LIKE LIPASE, FLAVODOXIN-LIKE, KEYWDS 2 STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 3 PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 01-FEB-23 3P94 1 REMARK SEQADV LINK REVDAT 3 25-OCT-17 3P94 1 REMARK REVDAT 2 20-JUL-11 3P94 1 KEYWDS REVDAT 1 03-NOV-10 3P94 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF A GDSL-LIKE LIPASE (BDI_0976) FROM JRNL TITL 2 PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.93 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.8.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 60913 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 3086 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3807 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2004 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3606 REMARK 3 BIN R VALUE (WORKING SET) : 0.1984 REMARK 3 BIN FREE R VALUE : 0.2374 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.28 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 201 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6364 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 714 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.15450 REMARK 3 B22 (A**2) : 0.87600 REMARK 3 B33 (A**2) : 3.27850 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.32310 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6707 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 9130 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3138 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 177 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 987 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6707 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 872 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 8443 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.95 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.95 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 13.8911 19.7015 11.9436 REMARK 3 T TENSOR REMARK 3 T11: -0.1013 T22: -0.0377 REMARK 3 T33: 0.0008 T12: -0.0068 REMARK 3 T13: 0.0245 T23: 0.0022 REMARK 3 L TENSOR REMARK 3 L11: 0.9033 L22: 0.9179 REMARK 3 L33: 0.8716 L12: 0.0489 REMARK 3 L13: -0.1420 L23: 0.2013 REMARK 3 S TENSOR REMARK 3 S11: -0.0372 S12: 0.0250 S13: -0.0896 REMARK 3 S21: -0.0418 S22: 0.0243 S23: 0.0232 REMARK 3 S31: 0.0295 S32: -0.0203 S33: 0.0128 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): -23.9186 37.4449 32.5281 REMARK 3 T TENSOR REMARK 3 T11: -0.0808 T22: -0.0423 REMARK 3 T33: 0.0013 T12: 0.0014 REMARK 3 T13: 0.0109 T23: -0.0207 REMARK 3 L TENSOR REMARK 3 L11: 1.0145 L22: 0.5834 REMARK 3 L33: 0.7586 L12: -0.0119 REMARK 3 L13: -0.0876 L23: 0.1203 REMARK 3 S TENSOR REMARK 3 S11: -0.0221 S12: -0.0848 S13: 0.0756 REMARK 3 S21: 0.0026 S22: 0.0266 S23: -0.0564 REMARK 3 S31: -0.0341 S32: 0.0425 S33: -0.0045 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN C REMARK 3 ORIGIN FOR THE GROUP (A): -25.8562 14.3844 11.6764 REMARK 3 T TENSOR REMARK 3 T11: -0.0751 T22: -0.0553 REMARK 3 T33: 0.0192 T12: 0.0089 REMARK 3 T13: 0.0238 T23: -0.0114 REMARK 3 L TENSOR REMARK 3 L11: 0.5268 L22: 0.7737 REMARK 3 L33: 0.8923 L12: 0.2030 REMARK 3 L13: -0.0024 L23: 0.5051 REMARK 3 S TENSOR REMARK 3 S11: 0.0447 S12: 0.0107 S13: -0.0405 REMARK 3 S21: -0.0012 S22: 0.0356 S23: -0.0911 REMARK 3 S31: 0.0552 S32: 0.0691 S33: -0.0803 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN D REMARK 3 ORIGIN FOR THE GROUP (A): 15.4946 37.1228 37.6645 REMARK 3 T TENSOR REMARK 3 T11: -0.1139 T22: -0.0055 REMARK 3 T33: -0.0411 T12: 0.0239 REMARK 3 T13: 0.0267 T23: -0.0053 REMARK 3 L TENSOR REMARK 3 L11: 0.8738 L22: 1.1494 REMARK 3 L33: 1.2133 L12: -0.0357 REMARK 3 L13: 0.0570 L23: 0.4989 REMARK 3 S TENSOR REMARK 3 S11: 0.0323 S12: -0.1598 S13: 0.0589 REMARK 3 S21: 0.0725 S22: -0.0157 S23: 0.0293 REMARK 3 S31: -0.0022 S32: 0.0057 S33: -0.0166 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. REMARK 3 THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 2. POLYETHYLENE GLYCOL FRAGMENT (PG4) MODELED IS REMARK 3 PRESENT PROTEIN/CRYSTALLIZATION/CRYO BUFFER. 3. NON- REMARK 3 CRYSTALLOGRAPHIC RESTRAINTS WERE APPLIED DURING REFINEMENT REMARK 3 (AUTONCS). 4. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. REMARK 4 REMARK 4 3P94 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1000062111. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.86 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97913 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60928 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 48.812 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.93 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.55200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30.40% POLYETHYLENE GLYCOL 4000, 0.20M REMARK 280 SODIUM ACETATE, 0.1M TRIS PH 8.86, NANODROP, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.18000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE REMARK 300 ASSIGNMENT OF A MONOMER AS A PREDOMINANT OLIGOMERIZATION STATE IN REMARK 300 SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 72.80000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY C 0 REMARK 465 GLU C 25 REMARK 465 LYS C 26 REMARK 465 LYS C 227 REMARK 465 GLY D 0 REMARK 465 GLU D 25 REMARK 465 LYS D 227 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 43 CD CE NZ REMARK 470 LYS A 176 CE NZ REMARK 470 LYS A 216 CE NZ REMARK 470 LYS A 224 CD CE NZ REMARK 470 LYS C 43 CE NZ REMARK 470 GLU C 191 CG CD OE1 OE2 REMARK 470 LYS C 224 CD CE NZ REMARK 470 LYS D 216 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 47 -81.69 -93.26 REMARK 500 ASN A 53 -145.25 -104.79 REMARK 500 VAL A 93 -69.22 -131.00 REMARK 500 VAL A 204 -49.30 -131.85 REMARK 500 ASN B 47 -83.93 -92.31 REMARK 500 ASN B 53 -145.21 -104.88 REMARK 500 VAL B 93 -68.72 -130.59 REMARK 500 VAL B 204 -55.59 -128.54 REMARK 500 ASN C 47 -82.42 -90.94 REMARK 500 ASN C 53 -145.76 -103.17 REMARK 500 VAL C 93 -68.83 -130.46 REMARK 500 VAL C 204 -55.61 -125.03 REMARK 500 ASN D 47 -83.38 -91.04 REMARK 500 ASN D 53 -145.27 -104.13 REMARK 500 VAL D 93 -67.46 -132.37 REMARK 500 VAL D 204 -58.57 -120.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PG4 A 228 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 228 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 229 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 406137 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT (RESIDUES 25-227) WAS EXPRESSED WITH A PURIFICATION REMARK 999 TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3P94 A 25 227 UNP A6LAN0 A6LAN0_PARD8 25 227 DBREF 3P94 B 25 227 UNP A6LAN0 A6LAN0_PARD8 25 227 DBREF 3P94 C 25 227 UNP A6LAN0 A6LAN0_PARD8 25 227 DBREF 3P94 D 25 227 UNP A6LAN0 A6LAN0_PARD8 25 227 SEQADV 3P94 GLY A 0 UNP A6LAN0 EXPRESSION TAG SEQADV 3P94 GLY B 0 UNP A6LAN0 EXPRESSION TAG SEQADV 3P94 GLY C 0 UNP A6LAN0 EXPRESSION TAG SEQADV 3P94 GLY D 0 UNP A6LAN0 EXPRESSION TAG SEQRES 1 A 204 GLY GLU LYS GLY ASP TRP ALA GLN PHE GLY ARG TYR ALA SEQRES 2 A 204 GLU ALA ASN LYS THR VAL LYS VAL PRO SER ASN VAL VAL SEQRES 3 A 204 PHE MSE GLY ASN SER ILE THR ASP GLY TRP TRP PRO ALA SEQRES 4 A 204 ASP SER THR PHE PHE ILE ARG ASN ASN PHE VAL ASP ARG SEQRES 5 A 204 GLY ILE SER GLY GLN THR THR SER GLU MSE LEU VAL ARG SEQRES 6 A 204 PHE ARG GLN ASP VAL ILE ASN LEU LYS PRO LYS ALA VAL SEQRES 7 A 204 VAL ILE LEU ALA GLY ILE ASN ASP ILE ALA HIS ASN ASN SEQRES 8 A 204 GLY VAL ILE ALA LEU GLU ASN VAL PHE GLY ASN LEU VAL SEQRES 9 A 204 SER MSE ALA GLU LEU ALA LYS ALA ASN HIS ILE LYS VAL SEQRES 10 A 204 ILE PHE CYS SER VAL LEU PRO ALA TYR ASP PHE PRO TRP SEQRES 11 A 204 ARG PRO GLY MSE GLN PRO ALA ASP LYS VAL ILE GLN LEU SEQRES 12 A 204 ASN LYS TRP ILE LYS GLU TYR ALA ASP LYS ASN GLY LEU SEQRES 13 A 204 THR TYR VAL ASP TYR HIS SER ALA MSE LYS ASP GLU ARG SEQRES 14 A 204 ASN GLY LEU PRO ALA ASN LEU SER LYS ASP GLY VAL HIS SEQRES 15 A 204 PRO THR LEU GLU GLY TYR LYS ILE MSE GLU LYS ILE VAL SEQRES 16 A 204 LEU GLU ALA ILE HIS LYS THR VAL LYS SEQRES 1 B 204 GLY GLU LYS GLY ASP TRP ALA GLN PHE GLY ARG TYR ALA SEQRES 2 B 204 GLU ALA ASN LYS THR VAL LYS VAL PRO SER ASN VAL VAL SEQRES 3 B 204 PHE MSE GLY ASN SER ILE THR ASP GLY TRP TRP PRO ALA SEQRES 4 B 204 ASP SER THR PHE PHE ILE ARG ASN ASN PHE VAL ASP ARG SEQRES 5 B 204 GLY ILE SER GLY GLN THR THR SER GLU MSE LEU VAL ARG SEQRES 6 B 204 PHE ARG GLN ASP VAL ILE ASN LEU LYS PRO LYS ALA VAL SEQRES 7 B 204 VAL ILE LEU ALA GLY ILE ASN ASP ILE ALA HIS ASN ASN SEQRES 8 B 204 GLY VAL ILE ALA LEU GLU ASN VAL PHE GLY ASN LEU VAL SEQRES 9 B 204 SER MSE ALA GLU LEU ALA LYS ALA ASN HIS ILE LYS VAL SEQRES 10 B 204 ILE PHE CYS SER VAL LEU PRO ALA TYR ASP PHE PRO TRP SEQRES 11 B 204 ARG PRO GLY MSE GLN PRO ALA ASP LYS VAL ILE GLN LEU SEQRES 12 B 204 ASN LYS TRP ILE LYS GLU TYR ALA ASP LYS ASN GLY LEU SEQRES 13 B 204 THR TYR VAL ASP TYR HIS SER ALA MSE LYS ASP GLU ARG SEQRES 14 B 204 ASN GLY LEU PRO ALA ASN LEU SER LYS ASP GLY VAL HIS SEQRES 15 B 204 PRO THR LEU GLU GLY TYR LYS ILE MSE GLU LYS ILE VAL SEQRES 16 B 204 LEU GLU ALA ILE HIS LYS THR VAL LYS SEQRES 1 C 204 GLY GLU LYS GLY ASP TRP ALA GLN PHE GLY ARG TYR ALA SEQRES 2 C 204 GLU ALA ASN LYS THR VAL LYS VAL PRO SER ASN VAL VAL SEQRES 3 C 204 PHE MSE GLY ASN SER ILE THR ASP GLY TRP TRP PRO ALA SEQRES 4 C 204 ASP SER THR PHE PHE ILE ARG ASN ASN PHE VAL ASP ARG SEQRES 5 C 204 GLY ILE SER GLY GLN THR THR SER GLU MSE LEU VAL ARG SEQRES 6 C 204 PHE ARG GLN ASP VAL ILE ASN LEU LYS PRO LYS ALA VAL SEQRES 7 C 204 VAL ILE LEU ALA GLY ILE ASN ASP ILE ALA HIS ASN ASN SEQRES 8 C 204 GLY VAL ILE ALA LEU GLU ASN VAL PHE GLY ASN LEU VAL SEQRES 9 C 204 SER MSE ALA GLU LEU ALA LYS ALA ASN HIS ILE LYS VAL SEQRES 10 C 204 ILE PHE CYS SER VAL LEU PRO ALA TYR ASP PHE PRO TRP SEQRES 11 C 204 ARG PRO GLY MSE GLN PRO ALA ASP LYS VAL ILE GLN LEU SEQRES 12 C 204 ASN LYS TRP ILE LYS GLU TYR ALA ASP LYS ASN GLY LEU SEQRES 13 C 204 THR TYR VAL ASP TYR HIS SER ALA MSE LYS ASP GLU ARG SEQRES 14 C 204 ASN GLY LEU PRO ALA ASN LEU SER LYS ASP GLY VAL HIS SEQRES 15 C 204 PRO THR LEU GLU GLY TYR LYS ILE MSE GLU LYS ILE VAL SEQRES 16 C 204 LEU GLU ALA ILE HIS LYS THR VAL LYS SEQRES 1 D 204 GLY GLU LYS GLY ASP TRP ALA GLN PHE GLY ARG TYR ALA SEQRES 2 D 204 GLU ALA ASN LYS THR VAL LYS VAL PRO SER ASN VAL VAL SEQRES 3 D 204 PHE MSE GLY ASN SER ILE THR ASP GLY TRP TRP PRO ALA SEQRES 4 D 204 ASP SER THR PHE PHE ILE ARG ASN ASN PHE VAL ASP ARG SEQRES 5 D 204 GLY ILE SER GLY GLN THR THR SER GLU MSE LEU VAL ARG SEQRES 6 D 204 PHE ARG GLN ASP VAL ILE ASN LEU LYS PRO LYS ALA VAL SEQRES 7 D 204 VAL ILE LEU ALA GLY ILE ASN ASP ILE ALA HIS ASN ASN SEQRES 8 D 204 GLY VAL ILE ALA LEU GLU ASN VAL PHE GLY ASN LEU VAL SEQRES 9 D 204 SER MSE ALA GLU LEU ALA LYS ALA ASN HIS ILE LYS VAL SEQRES 10 D 204 ILE PHE CYS SER VAL LEU PRO ALA TYR ASP PHE PRO TRP SEQRES 11 D 204 ARG PRO GLY MSE GLN PRO ALA ASP LYS VAL ILE GLN LEU SEQRES 12 D 204 ASN LYS TRP ILE LYS GLU TYR ALA ASP LYS ASN GLY LEU SEQRES 13 D 204 THR TYR VAL ASP TYR HIS SER ALA MSE LYS ASP GLU ARG SEQRES 14 D 204 ASN GLY LEU PRO ALA ASN LEU SER LYS ASP GLY VAL HIS SEQRES 15 D 204 PRO THR LEU GLU GLY TYR LYS ILE MSE GLU LYS ILE VAL SEQRES 16 D 204 LEU GLU ALA ILE HIS LYS THR VAL LYS MODRES 3P94 MSE A 51 MET SELENOMETHIONINE MODRES 3P94 MSE A 85 MET SELENOMETHIONINE MODRES 3P94 MSE A 129 MET SELENOMETHIONINE MODRES 3P94 MSE A 157 MET SELENOMETHIONINE MODRES 3P94 MSE A 188 MET SELENOMETHIONINE MODRES 3P94 MSE A 214 MET SELENOMETHIONINE MODRES 3P94 MSE B 51 MET SELENOMETHIONINE MODRES 3P94 MSE B 85 MET SELENOMETHIONINE MODRES 3P94 MSE B 129 MET SELENOMETHIONINE MODRES 3P94 MSE B 157 MET SELENOMETHIONINE MODRES 3P94 MSE B 188 MET SELENOMETHIONINE MODRES 3P94 MSE B 214 MET SELENOMETHIONINE MODRES 3P94 MSE C 51 MET SELENOMETHIONINE MODRES 3P94 MSE C 85 MET SELENOMETHIONINE MODRES 3P94 MSE C 129 MET SELENOMETHIONINE MODRES 3P94 MSE C 157 MET SELENOMETHIONINE MODRES 3P94 MSE C 188 MET SELENOMETHIONINE MODRES 3P94 MSE C 214 MET SELENOMETHIONINE MODRES 3P94 MSE D 51 MET SELENOMETHIONINE MODRES 3P94 MSE D 85 MET SELENOMETHIONINE MODRES 3P94 MSE D 129 MET SELENOMETHIONINE MODRES 3P94 MSE D 157 MET SELENOMETHIONINE MODRES 3P94 MSE D 188 MET SELENOMETHIONINE MODRES 3P94 MSE D 214 MET SELENOMETHIONINE HET MSE A 51 8 HET MSE A 85 8 HET MSE A 129 8 HET MSE A 157 8 HET MSE A 188 8 HET MSE A 214 8 HET MSE B 51 8 HET MSE B 85 8 HET MSE B 129 8 HET MSE B 157 8 HET MSE B 188 8 HET MSE B 214 8 HET MSE C 51 13 HET MSE C 85 8 HET MSE C 129 8 HET MSE C 157 8 HET MSE C 188 8 HET MSE C 214 8 HET MSE D 51 13 HET MSE D 85 8 HET MSE D 129 8 HET MSE D 157 8 HET MSE D 188 8 HET MSE D 214 8 HET PG4 A 228 10 HET PG4 B 229 13 HETNAM MSE SELENOMETHIONINE HETNAM PG4 TETRAETHYLENE GLYCOL FORMUL 1 MSE 24(C5 H11 N O2 SE) FORMUL 5 PG4 2(C8 H18 O5) FORMUL 7 HOH *714(H2 O) HELIX 1 1 TYR A 35 LYS A 40 1 6 HELIX 2 2 ASN A 53 GLY A 58 1 6 HELIX 3 3 GLY A 58 ASP A 63 1 6 HELIX 4 4 THR A 65 ASN A 71 1 7 HELIX 5 5 THR A 81 VAL A 93 1 13 HELIX 6 6 ILE A 94 LEU A 96 5 3 HELIX 7 7 GLY A 106 ALA A 111 1 6 HELIX 8 8 ALA A 118 ASN A 136 1 19 HELIX 9 9 PRO A 159 ASN A 177 1 19 HELIX 10 10 ASP A 183 LYS A 189 1 7 HELIX 11 11 THR A 207 VAL A 226 1 20 HELIX 12 12 TYR B 35 LYS B 40 1 6 HELIX 13 13 ASN B 53 GLY B 58 1 6 HELIX 14 14 GLY B 58 ASP B 63 1 6 HELIX 15 15 THR B 65 ASN B 71 1 7 HELIX 16 16 THR B 81 VAL B 93 1 13 HELIX 17 17 ILE B 94 LEU B 96 5 3 HELIX 18 18 GLY B 106 ALA B 111 1 6 HELIX 19 19 ALA B 118 ASN B 136 1 19 HELIX 20 20 PRO B 159 ASN B 177 1 19 HELIX 21 21 ASP B 183 LYS B 189 1 7 HELIX 22 22 THR B 207 VAL B 226 1 20 HELIX 23 23 GLN C 31 ARG C 34 5 4 HELIX 24 24 TYR C 35 LYS C 40 1 6 HELIX 25 25 ASN C 53 GLY C 58 1 6 HELIX 26 26 GLY C 58 ASP C 63 1 6 HELIX 27 27 THR C 65 ASN C 71 1 7 HELIX 28 28 THR C 81 VAL C 93 1 13 HELIX 29 29 ILE C 94 LEU C 96 5 3 HELIX 30 30 GLY C 106 ALA C 111 1 6 HELIX 31 31 ALA C 118 ASN C 136 1 19 HELIX 32 32 GLN C 158 ASN C 177 1 20 HELIX 33 33 ASP C 183 LYS C 189 1 7 HELIX 34 34 THR C 207 VAL C 226 1 20 HELIX 35 35 TYR D 35 LYS D 40 1 6 HELIX 36 36 ASN D 53 GLY D 58 1 6 HELIX 37 37 GLY D 58 ASP D 63 1 6 HELIX 38 38 THR D 65 ASN D 71 1 7 HELIX 39 39 THR D 81 VAL D 93 1 13 HELIX 40 40 ILE D 94 LEU D 96 5 3 HELIX 41 41 GLY D 106 ALA D 111 1 6 HELIX 42 42 ALA D 118 ASN D 136 1 19 HELIX 43 43 PRO D 159 ASN D 177 1 19 HELIX 44 44 ASP D 183 LYS D 189 1 7 HELIX 45 45 THR D 207 VAL D 226 1 20 SHEET 1 A 5 PHE A 72 GLY A 76 0 SHEET 2 A 5 SER A 46 GLY A 52 1 N PHE A 50 O VAL A 73 SHEET 3 A 5 PRO A 98 LEU A 104 1 O VAL A 102 N VAL A 49 SHEET 4 A 5 LYS A 139 CYS A 143 1 O ILE A 141 N VAL A 101 SHEET 5 A 5 THR A 180 VAL A 182 1 O VAL A 182 N PHE A 142 SHEET 1 B 5 PHE B 72 GLY B 76 0 SHEET 2 B 5 SER B 46 GLY B 52 1 N PHE B 50 O VAL B 73 SHEET 3 B 5 PRO B 98 LEU B 104 1 O VAL B 102 N VAL B 49 SHEET 4 B 5 LYS B 139 CYS B 143 1 O ILE B 141 N VAL B 101 SHEET 5 B 5 THR B 180 VAL B 182 1 O VAL B 182 N PHE B 142 SHEET 1 C 5 PHE C 72 GLY C 76 0 SHEET 2 C 5 SER C 46 GLY C 52 1 N PHE C 50 O VAL C 73 SHEET 3 C 5 PRO C 98 LEU C 104 1 O VAL C 102 N MSE C 51 SHEET 4 C 5 LYS C 139 CYS C 143 1 O ILE C 141 N ILE C 103 SHEET 5 C 5 THR C 180 VAL C 182 1 O VAL C 182 N PHE C 142 SHEET 1 D 5 PHE D 72 GLY D 76 0 SHEET 2 D 5 SER D 46 GLY D 52 1 N PHE D 50 O VAL D 73 SHEET 3 D 5 PRO D 98 LEU D 104 1 O VAL D 102 N VAL D 49 SHEET 4 D 5 LYS D 139 CYS D 143 1 O ILE D 141 N ILE D 103 SHEET 5 D 5 THR D 180 VAL D 182 1 O VAL D 182 N PHE D 142 LINK C PHE A 50 N MSE A 51 1555 1555 1.34 LINK C MSE A 51 N GLY A 52 1555 1555 1.33 LINK C GLU A 84 N MSE A 85 1555 1555 1.33 LINK C MSE A 85 N LEU A 86 1555 1555 1.35 LINK C SER A 128 N MSE A 129 1555 1555 1.37 LINK C MSE A 129 N ALA A 130 1555 1555 1.35 LINK C GLY A 156 N MSE A 157 1555 1555 1.33 LINK C MSE A 157 N GLN A 158 1555 1555 1.32 LINK C ALA A 187 N MSE A 188 1555 1555 1.34 LINK C MSE A 188 N LYS A 189 1555 1555 1.35 LINK C ILE A 213 N MSE A 214 1555 1555 1.33 LINK C MSE A 214 N GLU A 215 1555 1555 1.35 LINK C PHE B 50 N MSE B 51 1555 1555 1.33 LINK C MSE B 51 N GLY B 52 1555 1555 1.34 LINK C GLU B 84 N MSE B 85 1555 1555 1.34 LINK C MSE B 85 N LEU B 86 1555 1555 1.36 LINK C SER B 128 N MSE B 129 1555 1555 1.36 LINK C MSE B 129 N ALA B 130 1555 1555 1.34 LINK C GLY B 156 N MSE B 157 1555 1555 1.35 LINK C MSE B 157 N GLN B 158 1555 1555 1.36 LINK C ALA B 187 N MSE B 188 1555 1555 1.34 LINK C MSE B 188 N LYS B 189 1555 1555 1.34 LINK C ILE B 213 N MSE B 214 1555 1555 1.34 LINK C MSE B 214 N GLU B 215 1555 1555 1.35 LINK C PHE C 50 N MSE C 51 1555 1555 1.36 LINK C MSE C 51 N GLY C 52 1555 1555 1.33 LINK C GLU C 84 N MSE C 85 1555 1555 1.34 LINK C MSE C 85 N LEU C 86 1555 1555 1.35 LINK C SER C 128 N MSE C 129 1555 1555 1.36 LINK C MSE C 129 N ALA C 130 1555 1555 1.34 LINK C GLY C 156 N MSE C 157 1555 1555 1.34 LINK C MSE C 157 N GLN C 158 1555 1555 1.36 LINK C ALA C 187 N MSE C 188 1555 1555 1.34 LINK C MSE C 188 N LYS C 189 1555 1555 1.35 LINK C ILE C 213 N MSE C 214 1555 1555 1.33 LINK C MSE C 214 N GLU C 215 1555 1555 1.34 LINK C PHE D 50 N MSE D 51 1555 1555 1.34 LINK C MSE D 51 N GLY D 52 1555 1555 1.32 LINK C GLU D 84 N MSE D 85 1555 1555 1.34 LINK C MSE D 85 N LEU D 86 1555 1555 1.35 LINK C SER D 128 N MSE D 129 1555 1555 1.36 LINK C MSE D 129 N ALA D 130 1555 1555 1.35 LINK C GLY D 156 N MSE D 157 1555 1555 1.34 LINK C MSE D 157 N GLN D 158 1555 1555 1.36 LINK C ALA D 187 N MSE D 188 1555 1555 1.35 LINK C MSE D 188 N LYS D 189 1555 1555 1.34 LINK C ILE D 213 N MSE D 214 1555 1555 1.35 LINK C MSE D 214 N GLU D 215 1555 1555 1.35 CISPEP 1 VAL A 44 PRO A 45 0 1.28 CISPEP 2 VAL B 44 PRO B 45 0 0.30 CISPEP 3 VAL C 44 PRO C 45 0 1.71 CISPEP 4 VAL D 44 PRO D 45 0 2.73 SITE 1 AC1 3 GLU A 120 PHE A 123 TRP A 169 SITE 1 AC2 8 LYS B 43 PRO B 45 SER B 46 ASN B 47 SITE 2 AC2 8 ASN B 71 ARG C 69 ASN C 70 ASN C 71 CRYST1 72.800 58.360 98.610 90.00 98.12 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013736 0.000000 0.001960 0.00000 SCALE2 0.000000 0.017135 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010244 0.00000